News

The Argentine has become a close ally of the Trump administration, including on health policy. Argentina has followed the U.S. out of the World Health Organization, and last month received a visit ...
Unlike traditional dry eye therapies, Tixel irequires no downtime. The entire treatment takes only two minutes, and patients ...
Aldeyra had received 2 complete response letters (CRL) from the FDA in April 2025 and November 2023 for past submissions.
A panelist discusses how the COAT trial demonstrated that twice-daily 0.09% cyclosporine improves multiple signs and symptoms ...
Washington University researchers found that raising a molecule called ApoM helps eye cells sweep away harmful cholesterol ...
Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...
A recent study found that older adults with diabetes who use a GLP-1 drug have double the risk of developing wet age-related ...
With overall syphilis rates on the rise, serologic testing for syphilis in patients with uveitis can help prevent permanent vision damage.
Phase 2 results were positive for ILYX-002, a topical immunomodulator for moderate to severe dry eye disease associated with systemic autoimmune or inflammatory conditions, according to a press ...
Find the latest Ophthalmology news articles, videos, podcasts, and meeting coverage from medical experts and key opinion leaders you trust.
Topline data were announced from a phase 3 trial evaluating ST-100 ophthalmic solution for the treatment of dry eye disease.